Abstract
BackgroundSince publication of clinical trials regarding the efficacy of nintedanib in fibrosing ILD, including the ILD associated with autoimmune diseases, its clinical use has increased but not enough real-world data...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have